Functional imaging of HER2-positive metastatic breast cancer using 64Cu DOTA-trastuzumab positron emission tomography (PET)

被引：0
|
作者：
Mortimer, Joanne E.
Conti, Peter
Tong, Shan
Reyes, Jose
Carroll, Mary I.
Poku, Kofi
Colcher, David
Raubitschek, Andrew Antony
Bading, James R.
Miles, Joshua
机构：
[1] City Hope Canc Ctr, Beckman Res Inst, Duarte, CA USA
[2] USC, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
639
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Vinflunine in combination with trastuzumab for treatment of HER2-positive metastatic breast cancer
    Paridaens, R., Sr.
    Wildiers, H.
    Dalenc, F.
    Rixe, O.
    Cadic, V.
    Pinel, M.
    Roche, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [42] Biodistribution and pharmacokinetics of radiolabeled trastuzumab in HER2-positive metastatic breast cancer
    Hooge, MNLD
    Perik, PJ
    Gietema, JA
    Jager, PL
    Jonkman, S
    Kosterink, JGW
    Van Veldhuisen, DJJ
    Van der Graaf, WTA
    Sleijfer, DTH
    De Vries, EGE
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 210S - 210S
  • [43] Trastuzumab for HER2-Positive Metastatic Breast Cancer: Clinical and Economic Considerations
    Jeyakumar, Alwin
    Younis, Tallal
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2012, 6
  • [44] Very long response with trastuzumab for metastatic Her2-positive breast cancer
    Lai-Tiong, F.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2018, 39 (06) : 1002 - 1003
  • [45] Targeted treatments of HER2-positive metastatic breast cancer: trastuzumab and beyond
    Zardavas, Dimitrios
    Pugliano, Lina
    Ades, Felipe
    Bozovic-Spasojevic, Ivana
    Capelan, Marta
    de Azambuja, Evandro
    BREAST CANCER MANAGEMENT, 2012, 1 (03) : 217 - 233
  • [46] Pertuzumab in combination with trastuzumab and docetaxel for HER2-positive metastatic breast cancer
    Kawajiri, Hidemi
    Takashima, Tsutomu
    Kashiwagi, Shinichiro
    Noda, Satoru
    Onoda, Naoyoshi
    Hirakawa, Kosei
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (01) : 17 - 26
  • [47] Gold Nanoclusters Doped with 64Cu for CXCR4 Positron Emission Tomography Imaging of Breast Cancer and Metastasis
    Zhao, Yongfeng
    Detering, Lisa
    Sultan, Deborah
    Cooper, Matthew L.
    You, Meng
    Cho, Sangho
    Meier, Stephanie L.
    Luehmann, Hannah
    Sun, Guorong
    Rettig, Michael
    Dehdashti, Farrokh
    Wooley, Karen L.
    DiPersio, John F.
    Liu, Yongjian
    ACS NANO, 2016, 10 (06) : 5959 - 5970
  • [48] Positron emission tomography (PET) with 89Zr-labeled trastuzumab (89Zr-trastuzumab): Monitoring HER2 expression in HER2-positive gastric cancer in vivo
    Janjigian, Y. Y.
    Villegas, N. T.
    Holland, J. P.
    Shah, M. A.
    Divilov, V.
    Kelsen, D. P.
    Lewis, J. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [49] Incorporating 64Cu Detectnet® into our Positron Emission Tomography (PET) imaging protocol for neuroendocrine tumors (NETs).
    Schmitt, Martin
    Silvestros, Delynn
    Ruwe, Sarah
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [50] Evaluation of [64Cu]Cu-DOTA and [64Cu]Cu-CB-TE2A Chelates for Targeted Positron Emission Tomography with an αvβ6-Specific Peptide
    Hausner, Sven H.
    Kukis, David L.
    Gagnon, M. Karen J.
    Stanecki, Catherine E.
    Ferdani, Riccardo
    Marshall, John F.
    Anderson, Carolyn J.
    Sutcliffe, Julie L.
    MOLECULAR IMAGING, 2009, 8 (02) : 111 - 121
12345